KPTI

KARYOPHARM THERAPEUTICS INC

KPTI·48576U205·US·Common Stock·Healthcare - Biotechnology-13D/G

KPTI (KARYOPHARM THERAPEUTICS INC) is held by 44 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($10.7M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($10.1M), GOLDMAN SACHS GROUP INC ($5.3M). Net institutional sentiment: Bullish.

44
Holders
(1 Elite)
$47.8M
Total Value
74% (46)
Consensus
34 buying - 12 selling
13F: Insider & Congress:
KPTI

Smart Money Verdict

View all
Held by 44 funds
1 elite

Who's Trading

ActivistBlackRock, Inc.BlackRock, Inc.5.6%Jul 28, 2026
ActivistTRT. Rowe Price Investment Management, Inc.6.6%Jun 5, 2026
ActivistIKIkarian Capital, LLC0.0%May 15, 2026
InsiderPSPoulton StuartSell $4KMay 14, 2026
InsiderMMMano MichaelSell $3KMay 14, 2026
ActivistAAAffinity Asset Advisors, LLC8.6%May 14, 2026
ActivistADAdage Capital Management, L.P.8.1%May 13, 2026
InsiderRRRangwala ReshmaSell $4KApr 21, 2026
InsiderPAPaulson Richard A.Sell $116KMar 2, 2026
CongressAshley MoodyAshley MoodySale $1,001 - $15,000Feb 20, 2025

Top Holders

Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
1.9M$10.7M0.1%
46
Increased
1.8M(+328.7%)$10.1M0.0%
45
New
947,579$5.3M0.0%
37
New
739,745$4.1M0.0%
37
New
420,571$2.3M0.0%
36
Increased
257,903(+518.0%)$1.4M0.0%
41
Decreased
244,899(-1.1%)$1.4M0.0%
0
New
212,367$1.2M0.0%
35
Increased
206,133(+9.8%)$1.1M0.0%
28
Increased
194,017(+119.3%)$1.1M0.0%
41
Increased
191,527(+87.0%)$1.1M0.0%
39
Increased
164,443(+1281.4%)$915,9480.0%
40
Increased
151,232(+1.6%)$842,3620.0%
25
Unchanged
128,451$715,4720.0%
0
New
114,934$640,1820.0%
34
New
112,432$626,2460.0%
34
Increased
105,901(+198.0%)$589,8680.0%
39
Increased
105,414(+75.9%)$587,1560.0%
37
Increased
80,742(+37.0%)$449,7330.0%
21
Increased
79,081(+38.2%)$440,4810.0%
31

Showing 1-20 of 51

1 / 3
KPTIKPTIKARYOPHARM THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used